Kaiser Permanente-Riverside is a clinical research site located in Riverside, California, United States 92505.
Crixeo Health Trust Score: 87/100 (GOOD). This profile has not yet been claimed by the site owner.
Kaiser Permanente-Riverside has participated in 135 clinical trials with 81 currently active.
Therapeutic areas: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Stage IB Lung Non-Small Cell Carcinoma AJCC v7.
Sponsors: National Cancer Institute (NCI), SWOG Cancer Research Network, Wake Forest University Health Sciences.
Trust Score: 87/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Kaiser Permanente-Riverside has a Crixeo Trust Score of 87/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Kaiser Permanente-Riverside has 135 clinical trials on record, with 81 currently active. Their work covers Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Stage IB Lung Non-Small Cell Carcinoma AJCC v7.
Kaiser Permanente-Riverside has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.